Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Devlin

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantationDoris M Ponce, Craig Sauter, Sean Devlin, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic MalignanciesGunjan L Shah, Leyla Shune, Duncan Purtill, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort studyTiffany Y Sia, Qin Zhou, Sean Devlin, et al.
Journal of Geriatric Oncology|August 20, 2025
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patientsMark Y Jeng, Phillip Wong, Jessica R Flynn, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Blood Cancer Journal|January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patientsUrvi A Shah, Karissa Whiting, Sean Devlin, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantationDoris M Ponce, Craig Sauter, Sean Devlin, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic MalignanciesGunjan L Shah, Leyla Shune, Duncan Purtill, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort studyTiffany Y Sia, Qin Zhou, Sean Devlin, et al.
Journal of Geriatric Oncology|August 20, 2025
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patientsMark Y Jeng, Phillip Wong, Jessica R Flynn, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Blood Cancer Journal|January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patientsUrvi A Shah, Karissa Whiting, Sean Devlin, et al.
Pageof 8